Ce dossier présente la mise à jour des recommandations de l'"US Preventive Services Task Force" relatives à l'utilisation de médicaments pour réduire le risque de cancer du sein

Breast Cancer Chemoprevention—Can We Make a Case for Precision Medicine?

Daly, Mary B. ; Ross, Eric

Among women in the United States, breast cancer remains the most common cancer and is the second leading cause of cancer-related deaths. The median age at diagnosis for white women is 63 years and is younger for black women at 59 years. In addition to earlier age at diagnosis, breast cancer tends to be more aggressive in black women, and they are more likely to die of complications of the disease at every age. While incidence rates have remained relatively stable, mortality rates have [...]

Ce dossier présente la mise à jour des recommandations de l'"US Preventive Services Task Force" relatives à l'utilisation de médicaments pour réduire le risque de cancer du sein

Medication Use to Reduce Risk of Breast Cancer: US Preventive Services Task Force Recommendation Statement

US Preventive Services Task Force

Breast cancer is the most common nonskin cancer among women in the United States and the second leading cause of cancer death. The median age at diagnosis is 62 years, and an estimated 1 in 8 women will develop breast cancer at some point in their lifetime. African American women are more likely to die of breast cancer compared with women of other races.To update the 2013 US Preventive Services Task Force (USPSTF) recommendation on medications for risk reduction of primary breast cancer.The [...]

Ce dossier présente la mise à jour des recommandations de l'"US Preventive Services Task Force" relatives à l'utilisation de médicaments pour réduire le risque de cancer du sein

Medications to Reduce Breast Cancer Risk

Jin, Jill

The US Preventive Services Task Force (USPSTF) has recently published recommendations on taking medications to reduce breast cancer risk.

Ce dossier présente la mise à jour des recommandations de l'"US Preventive Services Task Force" relatives à l'utilisation de médicaments pour réduire le risque de cancer du sein

Medication Use for the Risk Reduction of Primary Breast Cancer in Women: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force

Nelson, Heidi D. ; Fu, Rongwei ; Zakher, Bernadette ; Pappas, Miranda ; McDonagh, Marian

Medications to reduce risk of breast cancer are effective for women at increased risk but also cause adverse effects.To update the 2013 US Preventive Services Task Force systematic review on medications to reduce risk of primary (first diagnosis) invasive breast cancer in women.Cochrane Central Register of Controlled Trials and Database of Systematic Reviews, EMBASE, and MEDLINE (January 1, 2013, to February 1, 2019); manual review of reference lists.Discriminatory accuracy studies of breast [...]

Ce dossier présente la mise à jour des recommandations de l'"US Preventive Services Task Force" relatives à l'utilisation de médicaments pour réduire le risque de cancer du sein

Medications to Reduce Breast Cancer Risk: Promise and Limitations

Pace, Lydia E. ; Keating, Nancy L.

Breast cancer is diagnosed among more than a quarter of a million women in the United States each year. Tamoxifen, raloxifene, and aromatase inhibitors can reduce women’s risk of developing breast cancer. With so many women at risk for breast cancer, these drugs have the potential to substantially affect public health. In this issue of JAMA, the US Preventive Services Task Force (USPSTF) reports updated recommendations regarding use of these medications. The task force recommends that [...]

A partir de l'analyse des rapports annuels publiés entre 2014 et 2019 par les différents centres du réseau américain de recherche et de lutte contre les cancers "The Cancer Prevention and Control Research Network", cette étude identifie les différentes actions menées puis examine leur lien avec les domaines couverts par les "Centers for Disease Control and Prevention's"

An application of the Science Impact Framework to the Cancer Prevention and Control Research Network from 2014-2018

Ko, Linda K. ; Jang, Sou H. ; Friedman, Daniela B. ; Glanz, Karen ; Leeman, Jennifer ; Hannon, Peggy A. ; Shannon, Jackilen ; Cole, Allison ; Williams, Rebecca ; Vu, Thuy

The Cancer Prevention and Control Research Network (CPCRN) is a strategic collaborative effort focused on accelerating the dissemination and implementation of evidence-based cancer prevention and control interventions to communities. In 2014, the CPCRN Coordinating Center began collecting information in alignment with the Centers for Disease Control and Prevention's (CDC) Science Impact Framework. The Science Impact Framework is a CDC-developed approach to trace and link CDC science to events [...]

A partir de l'analyse des rapports annuels publiés entre 2014 et 2019 par les différents centres du réseau américain de recherche et de lutte contre les cancers "The Cancer Prevention and Control Research Network", cette étude identifie les différentes actions menées puis examine leur lien avec les domaines couverts par les "Centers for Disease Control and Prevention's"

The Cancer Prevention and Control Research Network (CPCRN): Advancing public health and implementation science

White, Arica ; Sabatino, Susan A. ; Vinson, Cynthia ; Chambers, David ; White, Mary C.

The Cancer Prevention and Control Research Network (CPCRN) is one of the thematic networks of the United States' Centers for Disease Control and Prevention's (CDC) Prevention Research Centers. Network members are academic research centers in the United States who collaborate with public health and community partners to accelerate the use of evidence-based interventions in communities to reduce the burden of cancer, especially among underserved populations. CPCRN studies include geographically [...]